Literature DB >> 1427376

Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study.

C S Probert1, V Jayanthi, A C Wicks, J F Mayberry.   

Abstract

Mortality among 610 people with Crohn's disease identified in a population based study from 1972-89 was assessed. In Europeans the overall mortality was not increased, the standardised mortality ratio (SMR) was 71.8 (95% confidence interval (CI) 49 to 101). The SMR in South Asians was 0, (95% CI 0 to 1590). The SMR varied with the site of disease (chi 2 (4) = 10.5, p < 0.05) and was highest in those with duodenal and jejunal involvement (SMR = 210, 95% CI 44 to 621). Survival curve comparisons showed that colonic disease carried a worse prognosis than terminal ileal disease (chi-2 = 9, p < 0.01) or mixed site disease (chi-2 = 4.7, p < 0.05). Mortality was particularly high during the first six years. It was increased in patients who had undergone more than one resection (SMR = 137, 95% CI 28 to 401) or an ileoanal anastomosis (SMR = 357, 95% CI 9 to 1070), although no difference was significant. Mortality did not change significantly during the study. Such information needs to be made available, not just to patients, their families, and their doctors, but perhaps more importantly, to actuaries, insurers, and those advising employers.

Entities:  

Mesh:

Year:  1992        PMID: 1427376      PMCID: PMC1379491          DOI: 10.1136/gut.33.9.1226

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire.

Authors:  V Jayanthi; C S Probert; D Pinder; A C Wicks; J F Mayberry
Journal:  Q J Med       Date:  1992-02

2.  Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital.

Authors:  I T Weterman; I Biemond; A S Peña
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Employment problems and prospects for patients with inflammatory bowel disease.

Authors:  R J Wyke; F C Edwards; R N Allan
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

4.  Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease.

Authors:  J R Barton; A Ferguson
Journal:  Q J Med       Date:  1990-05

5.  Mortality in Crohn's disease--a clinical analysis.

Authors:  H A Andrews; P Lewis; R N Allan
Journal:  Q J Med       Date:  1989-05

6.  Mortality in Crohn's disease.

Authors:  P Prior; S Gyde; W T Cooke; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

7.  Mortality from Crohn's disease and ulcerative colitis in England-Wales and the U.S. from 1950 to 1983.

Authors:  A Sonnenberg
Journal:  Dis Colon Rectum       Date:  1986-10       Impact factor: 4.585

8.  Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.

Authors:  V Binder; C Hendriksen; S Kreiner
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

9.  An audit of Crohn's disease in a defined population.

Authors:  J F Mayberry; M J Dew; J S Morris; D B Powell
Journal:  J R Coll Physicians Lond       Date:  1983-07
  9 in total
  11 in total

1.  Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

Authors:  W J Sandborn; E V Loftus
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

2.  Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

Authors:  F L Wolters; M G Russel; J Sijbrandij; L J Schouten; S Odes; L Riis; P Munkholm; P Bodini; C O'Morain; I A Mouzas; E Tsianos; S Vermeire; E Monteiro; C Limonard; M Vatn; G Fornaciari; S Pereira; B Moum; R W Stockbrügger
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  Crohn's disease: why the disparity in mortality?

Authors:  E V Loftus
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 5.  Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

Authors:  Irene Modesto; Giovanni Perricone; Ambrogio Orlando; Mario Cottone
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.

Authors:  T Jess; E V Loftus; W S Harmsen; A R Zinsmeister; W J Tremaine; L J Melton; P Munkholm; W J Sandborn
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

7.  General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study.

Authors:  D Palli; G Trallori; C Saieva; O Tarantino; E Edili; G D'Albasio; F Pacini; G Masala
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

8.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

10.  Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire.

Authors:  C S Probert; V Jayanthi; A O Hughes; J R Thompson; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.